← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Bdh Pharma, Llc
Studio City, CA
$2,449,491
Total funding
2
Grants
Funding over time
peak $1.1M · FY2019–22$2M$1.5M$1M$500K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$2,449,491 · 2
By mechanism
R44$2,110,556 · 1
R43$338,935 · 1
Investigators at Bdh Pharma, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Development of cannabinoid-opioid combination with opioid sparing and synergistic analgesic effects to prevent opioid use disorder and overdose.$1,136,636
R44 · FY2022 · DA
Development of cannabinoid-opioid combination with opioid sparing and synergistic analgesic effects to prevent opioid use disorder and overdose.$973,920
R44 · FY2021 · DA
Development of cannabinoid-opioid combination with opioid sparing and synergistic analgesic effects to prevent opioid use disorder and overdose.$283,935
R43 · FY2019 · DA
Development of cannabinoid-opioid combination with opioid sparing and synergistic analgesic effects to prevent opioid use disorder and overdose.$55,000
R43 · FY2020 · DA